Next Article in Journal
Muscle–Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies
Next Article in Special Issue
The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease
Previous Article in Journal / Special Issue
A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
Open AccessReview

The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease

Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
*
Author to whom correspondence should be addressed.
Biomedicines 2017, 5(4), 61; https://doi.org/10.3390/biomedicines5040061
Received: 21 August 2017 / Revised: 20 September 2017 / Accepted: 9 October 2017 / Published: 17 October 2017
(This article belongs to the Special Issue Cell Therapy for the Treatment of GVHD)
Chronic graft-versus-host disease (cGVHD) is a leading cause of late morbidity and mortality following allogeneic stem cell transplantation. Current therapies, including corticosteroids and calcineurin inhibitors, are only effective in roughly 50% of cases; therefore, new treatment strategies are under investigation. What was previously felt to be a T cell disease has more recently been shown to involve activation of both T and B cells, as well as a number of cytokines. With a better understanding of its pathophysiology have come more expansive preclinical and clinical trials, many focused on B cell signaling. This report briefly reviews our current understanding of cGVHD pathophysiology and reviews clinical and preclinical trials with B cell-targeted agents. View Full-Text
Keywords: chronic graft-versus-host disease; B cell; rituximab; ibrutinib chronic graft-versus-host disease; B cell; rituximab; ibrutinib
MDPI and ACS Style

Rhoades, R.; Gaballa, S. The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease. Biomedicines 2017, 5, 61. https://doi.org/10.3390/biomedicines5040061

AMA Style

Rhoades R, Gaballa S. The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease. Biomedicines. 2017; 5(4):61. https://doi.org/10.3390/biomedicines5040061

Chicago/Turabian Style

Rhoades, Ruben; Gaballa, Sameh. 2017. "The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease" Biomedicines 5, no. 4: 61. https://doi.org/10.3390/biomedicines5040061

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop